AI generated summary of Pubmed citation/abstract with PMID 38093012

https://pubmed.ncbi.nlm.nih.gov/38093012

This new study presents an inhaled, single-dose, dry powder aerosol SARS-CoV-2 vaccine that induces strong systemic and mucosal immune responses, providing a promising multivalent platform for fighting COVID-19 and other respiratory infectious diseases.